Accrued Liabilities, Current of Xenetic Biosciences, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Xenetic Biosciences, Inc. quarterly Accrued Liabilities, Current in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Xenetic Biosciences, Inc. Accrued Liabilities, Current for the quarter ending 31 Dec 2024 was $610,648, a 7.4% increase year-over-year.
Source SEC data
View on sec.gov
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Xenetic Biosciences, Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $610,648 +$41,895 +7.4% 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q4 2023 $568,753 -$217,043 -28% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q4 2022 $785,796 -$245,794 -24% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $1,031,590 +$457,540 +80% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $873,010 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $653,126 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $590,380 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $574,050 +$110,063 +24% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q4 2019 $463,987 -$200,042 -30% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q4 2018 $664,029 -$471,624 -42% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 $800,376 -$313,070 -28% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $796,164 -$124,149 -13% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 $826,552 +$221,458 +37% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $1,135,653 +$296,765 +35% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 $1,113,446 -$375,483 -25% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $920,313 -$686,812 -43% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $605,094 -$931,517 -61% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $838,888 -$648,158 -44% 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 $1,488,929 +$107,535 +7.8% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $1,607,125 +$745,012 +86% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $1,536,611 +$601,577 +64% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $1,487,046 +$77,355 +5.5% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $1,381,394 +$628,457 +83% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 $862,113 +$69,186 +8.7% 30 Jun 2015 10-Q 19 Aug 2015 2015 Q2
Q1 2015 $935,034 -$157,484 -14% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 $1,409,691 -$417,176 -23% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $752,937 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 $792,927 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $1,092,518 31 Mar 2014 10-Q 20 May 2014 2014 Q1
Q4 2013 $1,826,867 +$1,370,123 +300% 31 Dec 2013 10-K 20 Jul 2015 2013 FY
Q4 2012 $456,744 31 Dec 2012 10-K 20 Jul 2015 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.